Page last updated: 2024-11-02

fenclonine and Diseases, Metabolic

fenclonine has been researched along with Diseases, Metabolic in 2 studies

Fenclonine: A selective and irreversible inhibitor of tryptophan hydroxylase, a rate-limiting enzyme in the biosynthesis of serotonin (5-HYDROXYTRYPTAMINE). Fenclonine acts pharmacologically to deplete endogenous levels of serotonin.

Research Excerpts

ExcerptRelevanceReference
"Both groups of carcinoid patients had a comparable decrease in their insulinogenic index."1.25Glucose intolerance in the carcinoid syndrome. ( Bivens, CH; Feldman, JM; Lebovitz, HE; Plonk, JW, 1975)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feldman, JM1
Plonk, JW1
Bivens, CH1
Lebovitz, HE1
Delvalle, JA1
Dienel, G1
Greengard, O1

Other Studies

2 other studies available for fenclonine and Diseases, Metabolic

ArticleYear
Glucose intolerance in the carcinoid syndrome.
    Diabetes, 1975, Volume: 24, Issue:7

    Topics: Adult; Aged; Carcinoid Tumor; Cyproheptadine; Diabetes Mellitus; Female; Fenclonine; Glucose; Glucos

1975
Comparison of alpha-methylphenylalanine and p-chlorophenylalanine as inducers of chronic hyperphenylalaninaemia in developing rats.
    The Biochemical journal, 1978, Mar-15, Volume: 170, Issue:3

    Topics: Animals; Brain; Fenclonine; Liver; Metabolic Diseases; Methyltyrosines; Phenylalanine; Phenylalanine

1978